FOR IMMEDIATE RELEASE Contact: Kara Batt (571) 239-6547 [email protected] #### May 20, 2015 — UAW Retiree Medical Benefits Trust (the “Trust”), the largest non-governmental payor of retiree health care benefits in the United States, has joined the Campaign for Sustainable Rx Pricing (CSRxP), a broad-based coalition working for solutions to skyrocketing prescription drug prices. “As […]
Two-fer ICYMI: Two WSJ Articles Highlight High Drug Prices
Sky-high drug prices have been causing their fair share of consternation among payers lately, and industry watchers have suspected for a while now that Vertex ($VRTX) will stir the pot when its new cystic fibrosis combo–expected to win FDA approval later this year–hits the market. But just how much will payers need to shell out for the new med over time? Prime Therapeutics has some ideas.
The Campaign for Sustainable Rx Pricing (CSRxP), a project of the National Coalition on Health Care, is hosting a Congressional briefing on Thursday, April 9.
April 09, 2015 Congressional Briefing Resources Peter Bach, MD, MAPP Director, Memorial Sloan Kettering’s Center for Health Policy and Outcomes The systemwide impact of new cancer therapies Matt Salo Executive Director, National Association of Medicaid Directors The impact on state Medicaid programs Leigh Purvis, MPA Director of Health Services Research, AARP’s Public Policy Institute The impact on beneficiaries’ […]
CSRxP Congressional Briefing The Impact of Rising Drug Costs on Patients, Providers and Public Programs Thursday, April 09, 2015 9:30 AM – 11:00 AM EST Capitol Visitors Center: Congressional Meeting Room South
Keynote Speaker Peter Bach, MD, MAPP Director The system wide impact of new cancer therapies Memorial Sloan Kettering’s Center for Health Policy and Outcomes The Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes, Dr. Bach is a physician, epidemiologist, writer, and recognized expert in healthcare policy whose work has been regularly featured […]
Reaction from National Coalition on Health Care President and CEO John Rother on key findings from the “Express Scripts 2014 Drug Trend Report.”